Articles for Covaxin Phase

Covaxin Phase 2-3 clinical trials for 2-18 age group to begin in June, youngest participant 2-year-old
3 years, 7 months ago

Covaxin Phase 2-3 clinical trials for 2-18 age group to begin in June, youngest participant 2-year-old

India Today  

The Phase 2 and 3 clinical trials of Bharat Biotech’s Covaxin in the age group of 2 to 18 years will begin in June, sources in the Hyderabad-based vaccine maker have said. Vaccine for children The Drugs Controller General of India on May 13 approved Bharat Biotech’s Covaxin to conduct the Phase 2-3 clinical trials on children aged 2-18 years. …

India Trial Age Sec Bharat Clinical Bharat Biotech
Bharat Biotech's Covaxin recommended by expert panel for phase 2/3 trials on children
3 years, 7 months ago

Bharat Biotech's Covaxin recommended by expert panel for phase 2/3 trials on children

India Today  

Bharat Biotech’s Covaxin shot has been recommended by the expert panel on Covid-19 for further trials on children aged between 2 and 18 years, said sources. The Subject Expert Committee on Covid-19 has recommended that Bharat Biotech be granted permission to conduct the phase 2/3 clinical trials of Covaxin, on children in the 2-18 age group. The Subject Expert Committee …

India Pti Bharat Clinical Bharat Biotech Covaxin Conduct Trials
Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study
3 years, 11 months ago

Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

India TV News  

India's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the results published in The Lancet Infectious Disease journal. The vaccine, codenamed BBV152, was well tolerated in all dose groups with no vaccine-related serious adverse events, noted the authors of the study funded …

India Trial Vaccine Bharat Biotech Lancet Bbv152 1 Trial
Excitement in some, disappointment in others: A peek into Covaxin phase 3 trial centres
3 years, 11 months ago

Excitement in some, disappointment in others: A peek into Covaxin phase 3 trial centres

India Today  

Three different cities, three different scenarios on Covaxin phase 3 trials! In Mumbai, doctors are finding it hard to convince people for the second dose; in Patna, more people have registered for clinical trials compared to phase 1 and phase 2; and in Jaipur, long lines of exuberant candidates are witnessed outside trial centres. 1,200 HUMAN TRIAL VOLUNTEERS AT PATNA …

India Mumbai Trial Candidates Trials Hospital Second
Congress questions DCGI nod to indigenous Covid vaccine, BJP says Opposition not proud of 'anything Indian'
3 years, 11 months ago

Congress questions DCGI nod to indigenous Covid vaccine, BJP says Opposition not proud of 'anything Indian'

India Today  

Hours after India's drug regulator approved indigenously developed 'Covaxin' of Bharat Biotech, Congress leaders raised concern over the grant of permission for the restricted use of Covaxin without its phase 3 trials. Soon after the approval to the coronavirus vaccines was announced, Congress leader Anand Sharma, who heads the Parliamentary panel on Home Affairs which dealt with the issue at …

Politics India Congress Trials Indian Opposition Vaccines
Exclusive: Covaxin can fight new Covid strain better than other vaccines, says ICMR chief
3 years, 11 months ago

Exclusive: Covaxin can fight new Covid strain better than other vaccines, says ICMR chief

India Today  

After questions were raised from various quarters regarding approval of Bharat Biotech's Covaxin and Oxford's Covishield, the Indian Council for Medical Research on Sunday assured that the two anti-coronavirus vaccines have greater efficacy and are safer than other vaccines conducting trials. However, ICMR chief Balram Bhargava, in an exclusive interview to India Today, said the emergency use authorisation was given …

India Indian Vaccines Covid Chief Virus Bhargava
Coronavirus | Data on Covaxin phase-3 trials submitted to DCGI: Bharat Biotech
3 years, 11 months ago

Coronavirus | Data on Covaxin phase-3 trials submitted to DCGI: Bharat Biotech

The Hindu  

Bharat Biotech in a statement issued on Saturday said the publication of its COVID vaccine ’s phase II trial data is undergoing the peer review process and that as a part of the regulatory guidelines all data has been submitted to the DCGI and CDSCO. The firm said that product development and clinical trial data for Covaxin has so far …

India Trial Vaccine Bharat Biotech Covaxin Phase
Coronavirus | Haryana Minister got only one dose of Covaxin, says government
4 years ago

Coronavirus | Haryana Minister got only one dose of Covaxin, says government

The Hindu  

A little over two weeks after the Haryana Home Minister Anil Vij participated in the Phase 3 trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, he tweeted on Saturday morning that he has tested positive for the virus. Responding to the social media post, the Union Health Ministry said: “Antibodies against the infection build up in a human being only after …

India Vaccine Bharat Biotech Dose Covaxin
Coronavirus | Bharat Biotech’s COVID-19 vaccine Covaxin enters phase-3 trials
4 years, 1 month ago

Coronavirus | Bharat Biotech’s COVID-19 vaccine Covaxin enters phase-3 trials

The Hindu  

The COVID-19 vaccine, Covaxin, being developed by Bharat Biotech is now undergoing phase-3 trials, Krishna Ella, Chairman and Managing Director, Bharat Biotech said on Monday. Coronavirus | Bharat Biotech plans to launch Covaxin in Q2 2021 upon approval from regulatory bodies Bharat Biotech is the only vaccine company in the world which has BSL3 production facility, he said. The city-based …

Covid Ella Phase Bharat Vaccine Bharat Biotech Biotech
Covaxin shows early promise
4 years, 4 months ago

Covaxin shows early promise

India Today  

Preliminary results from the human clinical trials of the indigenously developed Covid-19 vaccine, Covaxin, suggest that the drug does not have adverse side effects, says Dr C.M. In the first phase, the vaccine is being tested on a total of 375 volunteers, including 45 at AIIMS Patna. In an exclusive conversation with INDIA TODAY, Dr Singh says that while 113 …

India Trials Volunteers Second Singh Phase Patna